Meet the Cycle Vita™ team

Find out who you and your patients may expect to hear from during their SAJAZIR™ (icatibant) injection treatment journey.

SAJAZIR (icatibant) injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.1

NOT ACTUAL PATIENTS

Once enrolled in SAJAZIR, your eligible* patients may have access to Cycle Vita, our comprehensive patient support* program, designed to help them navigate their journey with hereditary angioedema.

Through Cycle Vita, you and your patients may be supported by three dedicated team members:

    • Access Specialist
    • Clinical Education Manager (CEM)
    • Field Reimbursement Manager

Find out below how our team can support you and your patients.

Erin Grant, Access Specialist

As an Access Specialist, Erin may support your patients in accessing their treatment as efficiently as possible. This includes assessing the need for a bridge shipment, insurance coverage support, and routing medication to the appropriate specialty pharmacy.

Find out more from Erin

Bryce Sobol, CEM

Our CEMs, like Bryce, may provide your patients with product support to help manage every aspect of the therapeutic routine, such as clinical education and 1-1 injection training.**

Find out more from Bryce

Rodney Martin, Field Reimbursement Specialist

As a Field Reimbursement Specialist, Rodney may work with you and your offices to help streamline patient access to SAJAZIR. This includes providing support throughout the reimbursement process, including assistance when an appeal is needed.

Find out more from Rodney

*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.

**SAJAZIR injection is a prefilled syringe for subcutaneous use.1 Patients should not inject SAJAZIR until they have been trained by a Cycle Vita Clinical Education Manager or their healthcare provider.

References

1. SAJAZIR™ (icatibant) Injection. Prescribing Information. Cycle Pharmaceuticals Limited.